drugset / Trial / NCT00779987

Autologous Serum Efficacy Study in Patients With Severe Dry Eye

NCT00779987 ↗

Phase 2 Completed 12 enrolled University of Chile
RandomizedCrossoverQuadruple-blindTreatment

Summary

The purpose of this study is to compare the reduction in symptomatology of patients with severe dry eye treated with autologous serum and conventional artificial tears.

Timeline

Start
2008-10
Primary completion
2008-12
Completion
2008-12

Outcome

Met primary endpoint

paper Autologous serum treatment showed a statistically significant (p = 0.002) higher OSDI decrease (50%) versus conventional treatment (22%). PMID 22670856 ↗

Drugs

EvaluationDrugModalityDoseRoute
Subject Autologous serum Unknown 20 % Other
Subject Systane Other / unclassified — —

Indications